Five things to know:
1. SeaSpine’s total revenue was $50.7 million, and its U.S. sales were $45.5 million, according to financial results posted May 3. Both global and U.S. revenue were up 21 percent compared to the same time last year.
2. U.S. spinal implants and enabling technologies saw an increased revenue of 31 percent year over year at $24.2 million.
3. U.S. orthobiologics sales grew 12 percent year over year at $21.3 million.
4. Additional milestones for the company in the first quarter include implantation of the 50,000th NanoMetalene interbody device and the full commercial launch of multiple products.
5. The company on May 3 also announced two leadership appointments. John Bostjancic was named chief operating and financial officer and Hollis Winkler was named senior vice president of human resources.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
